Companies /Healthcare

Artivion Inc

NYSE: AORT Medical Devices
$24.78
▲ $0.13 (+0.53%) today
Markets open · 3:15pm ET
Today · % change

Fundamentals

Market Cap
$1.2B
Profit Margin
-0.7%
Revenue (TTM)
$471.5M
EPS (TTM)
$-0.06
52-Week Range
$19 – $48
Street Target
$42.15

About Artivion

Artivion, Inc., based in Kennesaw, Georgia, is a global leader in the development and distribution of medical devices and implantable human tissues. The company specializes in a wide range of products for cardiac, vascular, neurologic, and pulmonary procedures, including BioGlue for surgical adhesion, PhotoFix for cardiac repair, and various stent grafts for aortic diseases. Artivion also offers vascular grafts, hemostats for surgical bleeding, cardiac laser therapy, and prosthetic heart valves, catering to healthcare professionals and facilities. Originally known as CryoLife, Artivion rebranded in 2022, continuing its commitment to innovative medical solutions since 1984.

AORT Coverage